Program: Main Sessions

ISAD > Georg RAJKA International Symposium on Atopic Dermatitis (ISAD) > 15th Georg RAJKA International Symposium on Atopic Dermatitis (ISAD) > Program: Main Sessions

Rajka 2025 Melbourne motto:
History, Memory, and Retelling

Keynote and Invited speakers

  • Katrina ABUABARA, USA
  • Sébastien BARBAROT, France
  • Rebecca BASSETT, Australia
  • Eung Ho CHOI, South Korea
  • John COMMON, UK
  • Sandipan DHAR, India
  • Carsten FLOHR, UK
  • Wenjing JIANG, China
  • Cindy MA, Australia
  • Marlys FASSETT, USA
  • Amir LATIFF, Malaysia
  • JiHyun LEE, South Korea
  • Adrian LOWE, Australia
  • Wei LI, China
  • Laura MacKAY, Australia
  • Laurent MISERY, France
  • Erereoghor OTROFANOWEI, Nigeria
  • Amy S. PALLER, USA
  • Peter SCHMID-GRENDELMEIER, Switzerland
  • Alain TAÏEB, France
  • Kim THOMAS, UK
  • Andreas WOLLENBERG, Germany
  • Margitta WORM, Germany
  • Xu YAO, China

Program

Please note all timings are based on Melbourne time zone.
➜ Australian Eastern Standard Time (AEDT) – UTC+11

Friday, October 24th, 2025 — PaCeCAD
PATIENT-CENTERED CARE IN ATOPIC DERMATITIS SESSIONS
07:30 Registration & Arrival Tea / Coffee
 
08:30
Opening introduction

Jean-François STALDER, France / John C. SU, Australia
08:35 P1. Misinformation in Atopic Dermatitis and Digital Tools to address it
Chair: Jean-François STALDER, France / Fanny SENTENAC, France
08:40
The concept of Patient Centered Approach in chronic skin disease (PCA)

Fanny SENTENAC, France
08:45
Tackling misinformation in social media: the example of Topical Corticosteroid Withdrawal (TSW)

Mikael ALSTERHOLM, Sweden
08:55
Dr Tiktok will see you now: The impact of social media on dermatology practice and patient perceptions

Alpana MOHTA, India
09:05
Disrupted Skin, Disrupted Trust: The Consequences of Social Media on Dermatology Patients and Practitioners

Hanof AHMED, Qatar
09:15
What should we expect from Large Language Model Chat bots in therapeutic education: uses, expected benefits, risks?

Pranvera SULEJMANI, USA
09:25 RT
Round Table: New communication tools in therapeutic education
Challenges, contributions, and limitations (Results of a survey on the role of AI in the management of AD)

All speakers
+ Kelly BARTA (ITSAN), USA
+ Kristin BELLENSON (NEA), USA
 
10:05 Refreshment Break 30 min.
 
10:35 P2. Atopic Dermatitis, Global Health Perspectives Worldwide
Chair: Fahafahantsoa RABENJA RAPELANORO, Madagascar / Tina MESARIČ, Slovenia
10:40
Atopic Dermatitis in Australia: specificities and challenges
The role of Health Care Providers in Australia: pharmacists, nurses

John C. SU, Australia
11:00
Eczema Support Australia: role and place of a patient advocacy group in the Australian patient journey

Melanie FUNK, Australia
11:10 RT
Round Table: Participants from other regions of the world
Given the particularities of each country, what is the common ground that would allow us to joint our efforts towards the same goal? Perhaps better acces to the right medicines? What are the 3 main stakes in terms of needs, tools and care?

All speakers
+ Amanda CRESSWELL-MELVILLE, Canada
+ Masaki FUTAMURA, Japan
+ Ellis HON, Hong-Kong, China
+ Kin Fon LEONG, Malaysia
+ Yong Kwang TAY, Singapore

11:50
Closure

Jean-François STALDER, including closing remarks by ISAD President Alain TAÏEB
 
12:00 Lunch break 01h00
 

Friday, October 24th, 2025 — Symposium
#day1
13:00 Welcome Addresses
Chair: John C. SU, Australia
13:00 WA
Acknowledgement of Country: Indigenous Welcome
13:05 WA1
Centenial of Georg RAJKA birth

Suzanne RAJKA, Norway
13:10 WA2
Welcome to Melbourne

John C. SU, Australia
13:15 WA3
President address

Alain TAÏEB, France
13:30 WA4
Welcome to Australia

Adriene LEE, Australia
13:35 RP
Reporting from pre meeting

Roberto TAKAOKA, Brazil
 
13:50 S1 Innate and Adaptive Immunity*
Chairs: Magdalena TRZECIAK, Poland / Anne Rosemary HALBERT, Australia
13:50 KL1
T helper 2 (Th2) cells in atopic dermatitis – learning from Inborn Errors of Immunity

Cindy MA, Australia
14:15 IL1
AD presentations in Inborn Errors of Immunity

Amir Hamzah ABDUL LATIFF, Malaysia
14:30 IL2
Can Peripheral T cell immunophenotypes in AD be useful to predict systemic treatment response?

Margitta WORM, Germany
14:50#1081 OL1
Comparative transcriptomic profiling of Asian atopic dermatitis and psoriasis reveals candidate molecular targets for precision therapy

Chang Ook PARK, South Korea
 
15:05 S2 Regulation of T Cell Immunity & Systemic Immunity and Immune Crosstalk
Chairs: Dirk-Jan HIJNEN, The Netherlands / Jason FOK, Australia
15:05 KL2
Skin-Resident Lymphocyte diversity and function

Laura MACKAY, Australia
15:30 IL3
Basophils: A Paradigm of Skin Neuroimmune crosstalk

Wenjing JIANG
15:50#1089 OL2
High-dimensional immune profiling of atopic dermatitis reveals a dysfunctional OX40+ regulatory T cell subset

Dong Hun LEE, South Korea
16:05#1002 OL3
Keratinocyte-Specific Progranulin Deficiency in psoriasiform or AD inflammation

Sung Eun CHANG, South Korea
16:20#1011 OL4
Basophil Response Patterns Reveal Divergent Effects of Dupilumab and Abrocitinib in Atopic Dermatitis

Wenjing JIANG, China
 
16:35 PS1 Poster presentation session 130 min. Refreshment Break & Visit Exhibits
➜ Check the Schedule
 
17:05 S3 Skin Barrier and Phenotypes
Chairs: Kyu Han KIM, South Korea / Linda MARTIN, Australia
17:05 KL3
Skin barrier research in atopic dermattis in the era of biologics

Eung Ho CHOI, South Korea
17:30 IL4
Clinical and molecular heterogeneities of atopic dermatitis

Wei LI, China
17:55#1068 OL5
Topical sulforaphane ameliorates atopic dermatitis by enhancing keratinocyte barrier function

Shan WANG, Japan
 
19:00 Welcome Reception @ Carlton Gardens, Melbourne Gallery in the Melbourne Museum 02h00
 

Saturday, October 25th, 2025 — Symposium
#day2
08:00 Registration & Arrival Tea / Coffee
 
08:30 S4 Georg RAJKA Centennial session
Chairs: Alain TAÏEB, France / John C. SU, Australia
08:30 KL4
100 years from the birth of Georg Rajka – atopic dermatitis over a century

Alain TAÏEB, France
08:55 IL5
Remembering the 1988 International Symposium on Atopic Dermatitis in Oslo, Norway

Roberto TAKAOKA, Brazil
09:10 IL6
Towards personalised therapy and potential disease modification

Peter SCHMID-GRENDELMEIER, Switzerland
09:35 IL7
New systemic therapies for AD

Amy S. PALLER, United States of America
 
10:00 PS2 Poster presentation session 230 min. Refreshment Break & Visit Exhibits
➜ Check the Schedule
 
10:30 S5 Epidemiology and Outcome Research
Chairs: Peter SCHMID-GRENDELMEIER, Switzerland / Rachel PETERS, Australia
10:30 KL5
Primary prevention of atopic dermatitis

Carsten FLOHR, United Kingdom
10:50 IL8
Skin lipids in the development of atopic dermatitis and food allergy

Adrian LOWE, Australia
11:10 IL9
Running remote eczema trials - opportunities and risks

Kim S. THOMAS, United Kingdom
11:30#1116 OL6
The impact of data source on global trends in atopic dermatitis prevalence

Sheng-Pei WANG, United States of America
11:45#1013 OL7
Global, regional and national burdens of atopic dermatitis in adolescents and young adults aged 10-24 years from 1990 to 2021: a trend analysis

Zhixuan LI, China
 
12:00 Lunch "Skin Matters" with GlobalSkin and GADA 01h30
 
13:30 S6 Itch and Prurigo*
Chairs: Diana Jane PURVIS, New Zealand / James BUTLER, Australia
13:30 KL6
Georg RAJKA: contributions to understanding AD, prurigo, and itch

Laurent MISERY, France
13:40 IL10
Itch and pain in atopic dermatitis and prurigo nodularis

Laurent MISERY, France
14:05 IL11
Known and novel regulators of itch cytokine IL-31 in type 2 disease

Marlys FASSETT, United States of America
14:30#1038 OL8
Atopic dermatitis predisposes dupilumab related conjunctivitis in prurigo nodularis patients

Piotr K KRAJEWSKI, Poland
 
15:00 PS3 Poster presentation session 330 min. Refreshment Break & Visit Exhibits
➜ Check the Schedule
 
15:30 S7 Potential Novel Pathways
Chairs: Yoko KATAOKA, Japan / Amy S. PALLER, United States of America
15:30#1050 OL9
EGFR-mediated autophagy by betacellulin improves atopic dermatitis pathogenesis

Ge PENG, Japan
15:45#1099 OL10
Context-Dependent Roles of Necroptotic Signalling in Cutaneous Inflammation: Implications for Atopic Dermatitis Pathogenesis and Therapeutic Targeting

Holly ANDERTON, Australia
 
16:00 S8 What's New from the Industry
Chairs: Chia-Yu CHU, Taiwan / George Andrew VARIGOS
16:00 SL1
Achieving minimal disease activity with JAK inhibition in atopic dermatitis (AbbVie)

Gayle Loraine ROSS, Australia
16:15 SL2
Lilly’s Commitment to Dermatology

William ROMERO GALLARDO, United Kingdom
16:20 SL3
DELTA TEEN Phase 3 Trial for Delgocitinib Cream, a non steroidal pan-JAK inhibitor, Demonstrates Efficacy and Safety in Adolescents with Moderate to Severe Chronic Hand Eczema

Teodora FESTINI, Germany
 
19:30 President’s Dinner @ Arts Centre Melbourne
Local Organizing Committee Cultural invitation with Peter C. DOHERTY 02h00
 

Sunday, October 26th, 2025 — Symposium
#day3
08:00 Registration & Arrival Tea / Coffee
 
08:30 S9 Exposome and Microbiome
Chairs: Lin MA, China / Pablo FERNANDEZ-PEÑAS, Australia
08:30 KL7
Skin metagenomics and metatranscriptomics to advance atopic dermatitis research

John COMMON, Singapore
08:50 IL12
Skin environmental and microbial crosstalk in AD pathogenesis

Xu YAO, China
09:10 IL13
Predict to prevent - Harnessing the Skin microbiome to transform atopic dermatitis care

Robin ROHAYEM
09:30#1091 OL11
Voluntary exercise modulates the gut microbiota and improves skin inflammation in a mouse model

Wanchen ZHAO, Japan
09:45#1065 OL12
Predicting Malassezia Sensitization in Atopic Dermatitis and Other Dermatoses Using Clinical and Immunological Markers: A Machine Learning Approach

Wanjin KIM, South Korea
 
10:00 PS4 Poster presentation session 430 min. Refreshment Break & Visit Exhibits
➜ Check the Schedule
 
10:30 S10 Systemic and New Therapies for Atopic Dermatitis
Chairs: Yong Kwang TAY, Singapore / Li-Chuen WONG, Australia
10:30 KL8
Cannabinoids in atopic dermatitis - exploring new treatment horizons

JiHyun LEE, South Korea
10:55#1177 OL13
Efficacy and Safety of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis: Results From TRuE-AD4, a Phase 3b, Randomized, Double-Blind, Vehicle-Controlled Study

Andreas WOLLENBERG, Germany
11:10#1071 OL14
Real-world analysis for long-term treatment of moderate-to-severe atopic dermatitis with adjusting doses of dupilumab

Huibin YIN, China
11:25#1141 OL15
Real-world efficacy of dupilumab and clinical predictors of treatment response in atopic dermatitis - a Polish multicenter retrospective study

Weronika ZYSK, Poland
11:40#1146 OL16
Application of real -world effectiveness outcomes of upadacitinib to Canadian treat-to-target criteria for atopic dermatitis: a retrospective multicenter analysis of 1 year data

Jensen YEUNG, Canada
 
12:00 Lunch (guest: William BARTON) 01h00
 
13:00 S11 Complications and Comorbidities of Atopic Dermatitis
Chairs: Roberto TAKAOKA, Brazil / Dedee MURRELL, Australia
13:00 KL9
Infectious complications and comorbidities of AD

Andreas WOLLENBERG, Germany
13:25 IL15
Disease-specific comorbidities in Atopic Dermatitis

Katrina ABUABARA, United States of America
13:45#1109 OL17
Elucidating the Long-Term Comorbidity Spectrum and Trajectories of Atopic Dermatitis

Yi XIAO, China
14:00#1092 OL18
The Risk of Venous Thromboembolism in Atopic Dermatitis: A Population-Based Cohort Study

Lina U IVERT, Sweden
14:15#1128 OL19
Dupilumab-associated ocular surface disease in atopic dermatitis has a distinct tear profile

Chia-Yu CHU, Taiwan
 
14:30 S12 Pediatric AD and Comparative Dermatology
Chairs: Ellis HON, Hong Kong, China / Anousha YAZDABADI, Australia
14:30 KL10
Managing children with moderate-to-severe AD & complications of therapy

Sébastien BARBAROT, France
14:55 IL16
Paediatric AD - syndromes and mimickers

Sandipan DHAR, India
15:15 IL17
Atopic Disease in Veterinary Practice

Rebecca BASSETT, Australia
15:35#1144 OL20
High Efficacy of 1% Benvitimod Cream in Pediatric Patients with Atopic Dermatitis: A Post-hoc Analysis of a Phase III Trial

Jianzhong ZHANG, China
 
15:50 PS5 Poster presentation session 530 min. Refreshment Break & Visit Exhibits
➜ Check the Schedule
 
16:20 S13 Atopic Dermatitis in Diverse Skin Types
Chairs: Kin Fon LEONG, Malaysia / Lena LY, Australia
16:20 KL11
AD in Africa: advancing research, care, and equity in diverse skin types

Erereoghor OTROFANOWEI, Nigeria
16:40#1129 OL21
Diagnostic Challenges of Atopic Dermatitis in the Elderly African Population: A Case Series Highlighting Mismanagement and Clinical Mimics.

Gloria Elisante MASENGA, Tanzania
16:55#1043 OL22
Exploratory study of skin microbiome among black skin children with atopic dermatitis in urban and rural areas in Mali

Lamissa CISSÉ, Mali
17:10#1083 OL23
Real-world management of Atopic Dermatitis in Sub Saharan Africa

Fahafahantsoa RAPELANORO RABENJA, Madagascar
 
17:25 Closing Ceremony
17:25 CC1
Best poster/presentation awards, local best posters

John C. SU, Australia
17:35 CC2
Next Rajka Symposium 2026: Beijing, China

Lin MA, China
17:40 CC3
Closing remarks

Alain TAÏEB, France
  
20251103031335

Endorsements

The 15th Georg RAJKA International Symposium on Atopic Dermatitis (ISAD) Melbourne 2025 is endorsed by the Australiasian College of Dermatology, its members can benefit from a discount on the registration fees.

Other supporters

➜ Check the other institutions endorsing the meeting and ask them for the discount code if you are a member